Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial
MetadataShow full item record
© 2017. Background: Physical activity is positively associated with survival and quality of life among breast cancer survivors. Despite these benefits, the majority of breast cancer survivors are insufficiently active. The potential health benefits of reducing sedentary behaviour (sitting time) in this population have not been extensively investigated. The ACTIVATE Trial will evaluate the efficacy of an intervention that combines wearable technology (the Garmin Vivofit2®) with traditional behavioural change approaches to increase physical activity and reduce sedentary behaviour performed by breast cancer survivors. Methods/design: This randomised controlled trial includes inactive, postmenopausal women diagnosed with stage I-III breast cancer who have completed their primary treatment. Participants are randomly assigned to the primary intervention group (Garmin Vivofit2®; behavioural feedback and goal setting session; and, five telephone-delivered health coaching sessions) or to the wait-list control group. The primary intervention is delivered over a 12-week period. The second 12-week period comprises a maintenance phase for the primary intervention group, and an abridged intervention (Garmin Vivofit2® only) for the wait-list control group. Moderate- to vigorous-intensity physical activity (MVPA) and sedentary behaviour are assessed by accelerometry at baseline (T1), end of intervention (T2), and end of maintenance phase (T3). Discussion: The ACTIVATE Trial is one of the first studies to incorporate wearable technology into an intervention for cancer survivors. If the use of wearable technology (in combination with behaviour change strategies, or alone) proves efficacious, it may become an inexpensive and sustainable addition to the health promotion strategies available to health care providers in the cancer survivorship context.Trial registration: ACTRN12616000175471.
Showing items related by title, author, creator and subject.
Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancerReeves, M.; Terranova, C.; Erickson, J.; Job, J.; Brookes, D.; McCarthy, N.; Hickman, I.; Lawler, S.; Fjeldsoe, B.; Healy, Genevieve; Winkler, E.; Janda, M.; Veerman, J.; Ware, R.; Prins, J.; Vos, T.; Demark-Wahnefried, W.; Eakin, E. (2016)BACKGROUND: Obesity, physical inactivity and poor diet quality have been associated with increased risk of breast cancer-specific and all-cause mortality as well as treatment-related side-effects in breast cancer survivors. ...
Effects of a Telephone-Delivered Multiple Health Behavior Change Intervention (CanChange) on Health and Behavioral Outcomes in Survivors of Colorectal Cancer: a Randomized Controlled TrialHawkes, Anna; Chambers, Suzanne; Pakenham, Kenneth; Patrao, Tania; Baade, Peter; Lynch, Brigid; Aitken, Joanne; Meng, Xingqiong; Courneya, Kerry (2013)Purpose: Colorectal cancer survivors are at risk for poor health outcomes because of unhealthy lifestyles, but few studies have developed translatable health behavior change interventions. This study aimed to determine ...
Wearable Activity Technology And Action-Planning (WATAAP) to promote physical activity in cancer survivors: Randomised controlled trial protocolMaxwell-Smith, C.; Cohen, P.; Platell, C.; Tan, P.; Levitt, M.; Salama, P.; Makin, G.; Tan, J.; Salfinger, S.; Kader Ali Mohan, G.; Kane, Robert; Hince, D.; Jiménez-Castuera, R.; Hardcastle, Sarah (2018)© 2018 Asociación Española de Psicología Conductual Background/Objective: Colorectal and gynecologic cancer survivors are at cardiovascular risk due to comorbidities and sedentary behaviour, warranting a feasible intervention ...